Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of March 2025, with a specific reporting date of March 27, 2025. The document serves as a notification of a transaction by a Person Discharging Managerial Responsibilities (PDMR) under Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively details a specific equity transaction involving the Chief Executive.
- Transaction Type: Exercise of Performance Share Plan (PSP) awards and subsequent partial sale.
- Shares Exercised: 964,464 ordinary shares (comprising 883,906 nil-cost options and 80,558 dividend equivalents).
- Shares Sold: 453,914 shares sold to cover tax and National Insurance liabilities.
- Transaction Price: £3.5633 per share.
- Total Proceeds from Sale: £1,617,431.76.
- Shares Retained: 510,550 shares (balance after tax sale).
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document reports a routine executive compensation event where an award granted in March 2015 and vested in March 2018 was exercised to prevent lapse.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is a statutory disclosure of a specific share transaction.
Investor Verification Checklist
- Verify the total number of shares retained by Andy Ransom following the tax sale (510,550 shares).
- Confirm the transaction date of March 26, 2025, on the London Stock Exchange (XLON).
- Check the share price of £3.5633 against the market price on the transaction date to assess execution timing.
- Note that this transaction relates to a legacy award (PSP 2006) and does not reflect new equity grants.